RESUMEN
Paramyxoviruses have been implicated in both animal and human infections. Some viruses, such as Morbilliviruses are responsible for large-scale epidemics. However, there are limited observations of these viruses crossing the host species barrier in nature. In 1994, in Australia a fatal infection in horses and humans was identified to be caused by a new Paramyxovirus, Hendra virus (HeV), and in 1998 in Malaysia, a closely related virus, Nipah virus (NiV) was responsible for fatal infections in pigs and humans. These two viruses were sufficiently different from previously described Paramyxoviruses to create a new genus, Henipaviruses. The natural reservoir of these viruses was the fruit bat (Pteropus), which is found in regions extending from the western Pacific to the eastern coast of Africa. Serological studies have established that as many as half the fruit bats in colonies throughout these regions may have antibodies against this family of viruses. The availability of diagnostic reagents for Nipah virus in humans have identified infections in several countries including, Bangladesh, India and Indonesia. In some of these epidemics, mortality in humans exceeds 75%. Deforestation is probably responsible for fruit bats leaving their ecological niches and approaching farms and villages. The infection of humans and animals may occur via contaminated foods or in certain cases by animals to man. At present, only within close families has human-to-human transmission been proposed. Henipavirus infections are probably more widespread than it is at presently known and so it is important to have an intense monitoring for these diseases, especially in countries where large-scale deforestation is happening.
Asunto(s)
Infecciones por Henipavirus/epidemiología , Henipavirus/aislamiento & purificación , Animales , Quirópteros/virología , Brotes de Enfermedades , Transmisión de Enfermedad Infecciosa , Henipavirus/patogenicidad , Infecciones por Henipavirus/veterinaria , Enfermedades de los Caballos/virología , Caballos , Humanos , Malasia/epidemiologíaRESUMEN
Measles virus (MeV) infection is characterized by the formation of multinuclear giant cells (MGC). We report that beta interferon (IFN-beta) production is amplified in vitro by the formation of virus-induced MGC derived from human epithelial cells or mature conventional dendritic cells. Both fusion and IFN-beta response amplification were inhibited in a dose-dependent way by a fusion-inhibitory peptide after MeV infection of epithelial cells. This effect was observed at both low and high multiplicities of infection. While in the absence of virus replication, the cell-cell fusion mediated by MeV H/F glycoproteins did not activate any IFN-alpha/beta production, an amplified IFN-beta response was observed when H/F-induced MGC were infected with a nonfusogenic recombinant chimerical virus. Time lapse microscopy studies revealed that MeV-infected MGC from epithelial cells have a highly dynamic behavior and an unexpected long life span. Following cell-cell fusion, both of the RIG-I and IFN-beta gene deficiencies were trans complemented to induce IFN-beta production. Production of IFN-beta and IFN-alpha was also observed in MeV-infected immature dendritic cells (iDC) and mature dendritic cells (mDC). In contrast to iDC, MeV infection of mDC induced MGC, which produced enhanced amounts of IFN-alpha/beta. The amplification of IFN-beta production was associated with a sustained nuclear localization of IFN regulatory factor 3 (IRF-3) in MeV-induced MGC derived from both epithelial cells and mDC, while the IRF-7 up-regulation was poorly sensitive to the fusion process. Therefore, MeV-induced cell-cell fusion amplifies IFN-alpha/beta production in infected cells, and this indicates that MGC contribute to the antiviral immune response.
Asunto(s)
Células Dendríticas/virología , Células Epiteliales/virología , Células Gigantes/virología , Interferón Tipo I/biosíntesis , Virus del Sarampión/inmunología , Virus del Sarampión/fisiología , Animales , Fusión Celular , Línea Celular , Núcleo Celular/química , Chlorocebus aethiops , Células Dendríticas/inmunología , Células Epiteliales/inmunología , Células Gigantes/citología , Células Gigantes/inmunología , Humanos , Factor 3 Regulador del Interferón/análisis , Factor 7 Regulador del Interferón/análisis , Virus del Sarampión/genética , Microscopía por Video , Proteínas Virales de Fusión/inmunología , Proteínas Virales de Fusión/fisiología , Proteínas Virales/inmunología , Proteínas Virales/fisiologíaRESUMEN
Emerging new viruses present an enormous challenge in understanding their aetiology, pathogenesis and epidemiology. In the last decade two new viruses : Nipah virus in Malaysia and Hendra virus in Australia crossed species barrier from flying foxes to infect humans. While Hendra virus mainly induced pulmonary disease, Nipah virus provoked encephalitis with 40-70 % of mortality, causing important health and economic problems. Based on the similar genome structure, these 2 viruses are classified in a new genus, Henipaviruses, within the family of Paramyxoviridae and both are ranked internationally as biosecurity level 4 agents. Recent studies on the virulence, host range and cell tropism of these human pathogens provide more insight into unique biological properties of the emergent zoonotic viruses.
RESUMEN
Nipah virus (NiV), a member of the Paramyxoviridae family, causes a zoonotic infection in which the reservoir, the fruit bat, may pass the infection to pigs and eventually to humans. In humans, the infection leads to encephalitis with >40 to 70% mortality. We have previously shown that polyclonal antibody directed to either one of two glycoproteins, G (attachment protein) or F (fusion protein), can protect hamsters from a lethal infection. In the present study, we have developed monoclonal antibodies (MAbs) to both glycoproteins and assessed their ability to protect animals against lethal NiV infection. We show that as little as 1.2 mug of an anti-G MAb protected animals, whereas more than 1.8 mug of anti-F MAb was required to completely protect the hamsters. High levels of either anti-G or anti-F MAbs gave a sterilizing immunity, whereas lower levels could protect against a fatal infection but resulted in an increase in anti-NiV antibodies starting 18 days after the viral challenge. Using reverse transcriptase PCR, the presence of NiV in the different organs could not be observed in MAb-protected animals. When the MAbs were given after infection, partial protection (50%) was observed with the anti-G MAbs when the animals were inoculated up to 24 h after infection, but administration of the anti-F MAbs protected some animals (25 to 50%) inoculated later during the infection. Our studies suggest that immunotherapy could be used for people who are exposed to NiV infections.
Asunto(s)
Anticuerpos Antivirales/administración & dosificación , Anticuerpos Antivirales/uso terapéutico , Infecciones por Henipavirus/tratamiento farmacológico , Infecciones por Henipavirus/prevención & control , Inmunización Pasiva , Virus Nipah/inmunología , Animales , Anticuerpos Monoclonales/administración & dosificación , Anticuerpos Monoclonales/inmunología , Anticuerpos Antivirales/sangre , Cricetinae , Ensayo de Inmunoadsorción Enzimática , Femenino , Mesocricetus , Ratones , Pruebas de Neutralización , ARN Viral/análisis , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Proteínas del Envoltorio Viral/inmunología , Proteínas Virales de Fusión/inmunologíaRESUMEN
The availability of new generation serological assays allowed re-evaluation of the antibody response to measles virus. IgM, IgA, total IgG, and IgG subclass responses were studied to the three major immunogenic measles virus proteins: the fusion protein (F), haemagglutinin (H), and nucleoprotein (N). Plasma samples were obtained from clinically diagnosed measles cases (n = 146) in Khartoum (Sudan) within a week after onset of the rash. Convalescent phase samples were collected from 32 of 117 laboratory-confirmed measles cases at different time points after onset of rash. Glycoprotein-specific IgM, IgG, and IgA antibody levels correlated well to the N-specific response. For IgG and IgA, responses to F were higher than to H. IgA antibody levels were undetectable in about one third of the laboratory-confirmed cases during the acute phase, but positive in all patients tested 1-4 weeks after infection. IgM levels declined rapidly and were lost 3-6 months after infection. IgA levels declined slowly during the first year but did not return to background levels during the subsequent 2 years. IgG avidity maturation was detected during a 3-6 month period after infection. The predominant IgG subclasses during the acute phase were IgG(1) and IgG(3). The latter was lost in the convalescent phase, while the IgG(4) isotype showed a slight rise afterwards. Interestingly, acute phase IgG(3) and IgA responses were associated, and were only detected in samples with high IgG. This study provides a comprehensive perspective on the antibody response to wild-type measles virus infection.
Asunto(s)
Anticuerpos Antivirales/sangre , Especificidad de Anticuerpos , Isotipos de Inmunoglobulinas/sangre , Virus del Sarampión/inmunología , Sarampión/inmunología , Proteínas Virales/inmunología , Enfermedad Aguda , Hemaglutininas Virales/inmunología , Humanos , Inmunoglobulina A/sangre , Inmunoglobulina G/sangre , Inmunoglobulina M/sangre , Lactante , Sarampión/virología , Proteínas de la Nucleocápside , Nucleoproteínas/inmunología , Proteínas del Núcleo Viral/inmunología , Proteínas Virales de Fusión/inmunologíaRESUMEN
Nipah virus, a member of the paramyxovirus family, was first isolated and identified in 1999 when the virus crossed the species barrier from fruit bats to pigs and then infected humans, inducing an encephalitis with up to 40% mortality. At present there is no prophylaxis for Nipah virus. We investigated the possibility of vaccination and passive transfer of antibodies as interventions against this disease. We show that both of the Nipah virus glycoproteins (G and F) when expressed as vaccinia virus recombinants induced an immune response in hamsters which protected against a lethal challenge by Nipah virus. Similarly, passive transfer of antibody induced by either of the glycoproteins protected the animals. In both the active and passive immunization studies, however, the challenge virus was capable of hyperimmunizing the vaccinated animals, suggesting that although the virus replicates under these conditions, the immune system can eventually control the infection.
Asunto(s)
Anticuerpos Antivirales/inmunología , Infecciones por Henipavirus/prevención & control , Inmunización Pasiva/métodos , Virus Nipah/inmunología , Vacunas Virales/administración & dosificación , Animales , Anticuerpos Antivirales/sangre , Cricetinae , Modelos Animales de Enfermedad , Células HeLa , Infecciones por Henipavirus/inmunología , Humanos , Mesocricetus , Vacunación/métodos , Virus Vaccinia/genética , Proteínas del Envoltorio Viral/genética , Proteínas del Envoltorio Viral/inmunología , Proteínas Virales de Fusión/genética , Proteínas Virales de Fusión/inmunología , Vacunas Virales/inmunologíaRESUMEN
Africa remains one of the major reservoirs of measles infection. Molecular epidemiological studies have permitted different measles virus isolates to be grouped into clades and genotypes; the major group, which has been identified as indigenous to Africa, is clade B. The viruses from epidemics in the Gambia (1993) and in the Cameroon (2001) were examined. In both studies, the homogeneity of the virus isolates within the epidemic as shown by sequence analysis revealed less than 0.2% variation of nucleotides between isolates. The measles viruses isolated in 1983 in Yaoundé, Cameroon, were designated as the B1 genotype. However, in 2001 only viruses belonging to the B3 genotype were found in this city. The viruses in the Gambia (1993) were also of the B3 genotype. However, these viruses could be distinguished from each other at the antigenic level and by comparative sequence analysis. The B3 Cameroon (2001) viruses were related to the proposed B3.1 subgroup, whereas the Gambian (1993) isolates corresponded to the B3.2 subgroup. The geographical distribution for the period 1993-2001 of these two viruses shows that B3.1 is found from the Sudan to Nigeria and Ghana extending south to the Cameroon, whereas the B3.2 genotype is found in West Africa. In Nigeria and Ghana, the viruses co-circulate. The identification of these viruses will permit more meaningful epidemiological studies after the proposed increase in measles vaccination coverage.
Asunto(s)
Virus del Sarampión/clasificación , Virus del Sarampión/genética , Sarampión/epidemiología , África Occidental/epidemiología , Anticuerpos Antivirales/sangre , Camerún/epidemiología , Niño , Preescolar , Citometría de Flujo , Gambia/epidemiología , Genotipo , Hemaglutininas , Hemaglutininas Virales/genética , Humanos , Lactante , Recién Nacido , Sarampión/virología , Datos de Secuencia Molecular , Proteínas de la Nucleocápside , Nucleoproteínas/genética , Filogenia , Análisis de Secuencia de ADN , Proteínas del Núcleo Viral/genéticaRESUMEN
Although initially developed in adult animals, novel viral vectors expressing recombinant measles antigens must eventually prove their success in the early life setting, where the efficacy of the currently used live-attenuated measles virus vaccine is limited. The immunological requirements for vaccine candidates include the generation of protective antibody responses as well as the induction of Th1 and cytotoxic T lymphocytes (CTL) responses, which is challenging in the neonatal setting. Here, we report that young BALB/c mice immunized with a single dose of a vaccinia-based NYVAC(K1L) vector generate adult-like antihemagglutinin (HA) antibody responses as well as adult-like Th1 and CTL responses. Despite this strong immunogenicity in early life, antibody responses (but not T-cell responses) to a single dose of NYVAC(K1L)-HA remained susceptible to inhibition by preexisting measles antibodies, calling for use of prime-boost strategies. NYVAC(K1L)-HA is the first attenuated live viral vector demonstrated as capable of inducing adult-like antibody, Th1, and CTL responses against measles in an early life murine immunization model, a capacity previously only reported for measles DNA vaccines.
Asunto(s)
Hemaglutininas Virales/inmunología , Sarampión/inmunología , Morbillivirus/inmunología , Animales , Animales Recién Nacidos , Anticuerpos Antivirales/análisis , Modelos Animales de Enfermedad , Femenino , Vectores Genéticos , Humanos , Inmunización Secundaria , Masculino , Sarampión/prevención & control , Vacuna Antisarampión/administración & dosificación , Ratones , Ratones Endogámicos BALB C , Organismos Libres de Patógenos Específicos , Linfocitos T Citotóxicos/inmunología , Células TH1/inmunología , Factores de Tiempo , Vacunas Atenuadas/administración & dosificación , Virus Vaccinia/genéticaRESUMEN
Despite the availability of safe and effective live attenuated vaccines, measles continues to be endemic in many developing countries. Control and elimination of measles will be especially difficult in East Africa, because of its limited infrastructure and political instability. We have studied diagnostic and epidemiological aspects of measles in suburban Khartoum, Sudan. Prospective studies were carried out in a cohort of clinically diagnosed measles cases and in a cohort of newborns, which were both followed up for 2 years. The studies intended to provide a rational basis for improvement of measles vaccination strategies, and strengthen measles research infrastructure in Khartoum.
Asunto(s)
Sarampión/prevención & control , Anticuerpos Antivirales/sangre , Estudios de Cohortes , Humanos , Lactante , Recién Nacido , Sarampión/diagnóstico , Sarampión/epidemiología , Vacuna Antisarampión/farmacología , Virus del Sarampión/genética , Virus del Sarampión/inmunología , Virus del Sarampión/aislamiento & purificación , Estudios Prospectivos , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Estudios Seroepidemiológicos , Pruebas Serológicas , Sudán/epidemiología , VacunaciónRESUMEN
Measles continues to be a major childhood disease in terms of global morbidity and mortality. In the main areas of its endemicity the only available means of diagnosis are based on clinical criteria: the presence of a maculopapular rash and fever accompanied by cough, coryza, and/or conjunctivitis. We have studied 38 clinically diagnosed cases of measles in Khartoum, Sudan, by means of serology, reverse transcriptase PCR (RT-PCR) on throat swabs and virus isolation from lymphocytes. On the basis of serology, 28 patients were diagnosed as having an acute measles virus (MV) infection, while in 10 cases the clinical symptoms proved to have other causes. It was shown that in cases with low serum immunoglobulin M (IgM) levels, an additional measurement of IgG or virus-neutralizing antibodies was necessary to discriminate between patients with an acute MV infection sampled during an early stage of the disease and patients who had experienced an MV infection in the more distant past. The serological laboratory diagnosis was validated by an MV-specific RT-PCR: for all confirmed measles cases tested a fragment of the correct size which hybridized with a third MV-specific primer could be amplified, while all serologically negative cases were also RT-PCR negative. MV could be isolated from 17 out of 23 of the serologically confirmed cases, demonstrating that virus isolation is less reliable as a diagnostic tool than serology or RT-PCR. This study stresses the urgent need for a rapid diagnostic field test for measles.
Asunto(s)
Virus del Sarampión/genética , Sarampión/virología , Adolescente , Anticuerpos Antivirales/sangre , Niño , Preescolar , Femenino , Humanos , Inmunoglobulina G/sangre , Lactante , Linfocitos/virología , Masculino , Sarampión/epidemiología , Sarampión/inmunología , Virus del Sarampión/clasificación , Virus del Sarampión/aislamiento & purificación , Faringe/virología , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Serotipificación , Población Suburbana/estadística & datos numéricos , Sudán/epidemiologíaRESUMEN
The limited induction of Th1 and cytotoxic immune responses is regarded as the main reason for the increased susceptibility to intracellular microorganisms in early life. Recently, in vitro IL-12 supplementation was shown to enhance the limited IFN-gamma release of measles-specific infant T cells. Using a series of IL-12 delivery systems, we show here that in vivo IL-12 supplementation may enhance early life murine Th1 responses to two model vaccine antigens, measles virus hemagglutinin and tetanus toxin peptide. However, this required multiple repeat injections of recombinant rIL-12, which were poorly tolerated in young mice. Local IL-12 delivery by an IL-12 expressing canarypox vector proved safe but failed to modulate vaccine responses. An IL-12 DNA plasmid or a CD40L DNA plasmid efficiently enhanced neonatal Th1 responses to measles hemagglutinin DNA vaccine. However, both plasmids only enhanced Th1 responses to DNA and not to peptide, protein, or live viral vaccines. Thus, inducing adult-like Th1 responses may be achieved in vivo by inducing (CD40L) or substituting for (IL-12 supplementation) optimal activation of neonatal APC. However, these immunomodulatory effects appear limited to certain antigen-presentation approaches and may not be broadly applicable to vaccines.
Asunto(s)
Adyuvantes Inmunológicos , Interleucina-12/inmunología , Vacuna Antisarampión/inmunología , Toxoide Tetánico/inmunología , Células TH1/inmunología , Envejecimiento/inmunología , Animales , Anticuerpos Antibacterianos/sangre , Anticuerpos Antivirales/sangre , Antígenos Bacterianos/inmunología , Antígenos CD40/inmunología , Ligando de CD40 , Hemaglutininas Virales/inmunología , Inmunización , Interleucina-12/genética , Linfocinas/análisis , Virus del Sarampión/inmunología , Glicoproteínas de Membrana/genética , Glicoproteínas de Membrana/inmunología , Ratones , Ratones Endogámicos BALB C , Plásmidos/genética , Proteínas Recombinantes/inmunologíaRESUMEN
The development of an attenuated measles virus vaccine gave us a tool to combat a disease which has ravaged the child population throughout the centuries. Three decades later the vaccine has shown its qualities and its problems. Using this vaccine the WHO have decided on a measles eradication policy. This article discusses some of the issues which are being addressed and possible solutions.
Asunto(s)
Vacuna Antisarampión/inmunología , Animales , Humanos , Inmunización , Vacunas de ADN/inmunologíaRESUMEN
An intranasal vaccine vector would elicit protective immunity at the respiratory mucosa, the portal of entry and the primary site for replication for measles virus (MV) and other respiratory viruses. In a murine model of pulmonary Shigella, we demonstrate here that a candidate-attenuated Shigella vaccine vector is safely tolerated in IFN-gamma deficient mice at an inoculum that is 1 million-fold higher than the inoculum of the wild-type parent strain that would be lethal for greater than 90% of these mice. Also, following intranasal inoculation, the Deltaasd Shigella harboring a DNA MV vaccine plasmid induces a vigorous MV-specific Th1-type (both CD8+ CTL and IFN-gamma) and, to a lesser degree, Th2-type responses among splenocytes in addition to low levels of IgG and IgA in the serum. Priming for MV-specific CTL responses was possible in mice that had prior infection with a wild-type Shigella of the same serotype. Remarkably, mice immunized by the intranasal route with attenuated Shigella harboring the DNA MV vaccine plasmid had a level of MV-specific CTL activity among splenocytes that was comparable with levels observed in mice immunized by the i.p. route with attenuated Salmonella typhi harboring the same DNA vaccine plasmid, despite the fact that Shigella remained localized to the lungs, yet Salmonella disseminated to the spleen following inoculation. Thus, Deltaasd Shigella represents a very useful vector for delivery of DNA vaccines to mucosal lymphoid tissues.
Asunto(s)
Vacuna Antisarampión/administración & dosificación , Shigella flexneri/genética , Shigella flexneri/inmunología , Vacunas de ADN/administración & dosificación , Administración Intranasal , Animales , Antígenos Virales/administración & dosificación , Antígenos Virales/genética , Expresión Génica , Vectores Genéticos , Inmunidad Mucosa , Interferón gamma/deficiencia , Interferón gamma/genética , Pulmón/inmunología , Pulmón/patología , Vacuna Antisarampión/genética , Ratones , Ratones Endogámicos BALB C , Ratones Noqueados , Ratones SCID , Mutación , Proteínas de la Nucleocápside , Nucleoproteínas/genética , Nucleoproteínas/inmunología , Seguridad , Células TH1/inmunología , Células Th2/inmunología , Vacunas Atenuadas/administración & dosificación , Vacunas Atenuadas/genética , Vacunas de ADN/genética , Proteínas Virales/genética , Proteínas Virales/inmunologíaRESUMEN
Although measles virus is an antigenically monotypic virus, nucleotide sequence analysis of the hemagglutinin and nucleoprotein genes has permitted the differentiation of a number of genotypes. In contrast, the fusion (F) protein is highly conserved; only three amino acid changes have been reported over a 40-year period. We have isolated a measles virus strain which did not react with an anti-F monoclonal antibody (MAb) which we had previously shown to be directed against a dominant antigenic site. This virus strain, Lys-1, had seven amino acid changes compared with the Edmonston strain. We have shown that a single amino acid at position 73 is responsible for its nonreactivity with the anti-F MAb. With the same MAb, antibody-resistant mutants were prepared from the vaccine strain. A single amino acid change at position 73 (R-->W) was observed. The possibility of selecting measles virus variants in vaccinated populations is discussed.
Asunto(s)
Anticuerpos Monoclonales/inmunología , Antígenos Virales/inmunología , Virus del Sarampión/inmunología , Mutación , Proteínas Virales de Fusión/inmunología , Humanos , Vacuna Antisarampión/inmunología , Virus del Sarampión/genética , Relación Estructura-Actividad , Proteínas Virales de Fusión/químicaRESUMEN
We have studied the immune responses to the two glycoproteins of the Morbillivirus canine distemper virus (CDV) after DNA vaccination of BALB/c mice. The plasmids coding for both CDV hemagglutinin (H) and fusion protein (F) induce high levels of antibodies which persist for more than 6 months. Intramuscular inoculation of the CDV DNA induces a predominantly immunoglobulin G2a (IgG2a) response (Th1 response), whereas gene gun immunization with CDV H evokes exclusively an IgG1 response (Th2 response). In contrast, the CDV F gene elicited a mixed, IgG1 and IgG2a response. Mice vaccinated (by gene gun) with either the CDV H or F DNA showed a class I-restricted cytotoxic lymphocyte response. Immunized mice challenged intracerebrally with a lethal dose of a neurovirulent strain of CDV were protected. However, approximately 30% of the mice vaccinated with the CDV F DNA became obese in the first 2 months following the challenge. This was not correlated with the serum antibody levels.
Asunto(s)
Virus del Moquillo Canino/genética , Virus del Moquillo Canino/inmunología , Moquillo/prevención & control , Vacunas de ADN/farmacología , Vacunas Virales/farmacología , Animales , Anticuerpos Antivirales/biosíntesis , Moquillo/inmunología , Perros , Femenino , Glicoproteínas/genética , Glicoproteínas/inmunología , Células HeLa , Hemaglutininas Virales/genética , Hemaglutininas Virales/inmunología , Humanos , Inmunidad Celular , Células L , Ratones , Ratones Endogámicos BALB C , Linfocitos T Citotóxicos/inmunología , Transfección , Proteínas Virales de Fusión/genética , Proteínas Virales de Fusión/inmunología , Proteínas Virales/genética , Proteínas Virales/inmunologíaRESUMEN
The susceptibility of CD46 (human membrane cofactor protein) transgenic mice to measles virus (MV) infection was investigated. Cell cultures (lung and kidney) established from transgenic and control mice showed that although both could be infected only those from the CD46+ mice gave fusion. A complete round of replication with the release of infectious virus was detected exclusively in the transgenic cell cultures whose permissiveness to MV was markedly less than that of Vero cells. The ability of MV to replicate in vivo in mice was studied using both vaccine and laboratory-adapted wild-type strains of virus. After intraperitoneal and intranasal inoculations of transgenic mice, virus replication could not be detected. In contrast intracerebral inoculation induced infection in both transgenic and nontransgenic mice. Our results from in vitro infection studies support the hypothesis that CD46 is a major host cell factor involved in the MV-induced fusion process and MV entry. The studies further indicate that MV tropism is not governed solely by the expression of the CD46 gene and that the high efficiency of the replicative cycles characteristic of fully permissive host cells requires additional factors, which are lacking in both transgenic and nontransgenic mice.
Asunto(s)
Antígenos CD/genética , Antígenos CD/fisiología , Virus del Sarampión/inmunología , Virus del Sarampión/patogenicidad , Sarampión/etiología , Glicoproteínas de Membrana/genética , Glicoproteínas de Membrana/fisiología , Administración Intranasal , Animales , Antígenos Virales/aislamiento & purificación , Secuencia de Bases , Encéfalo , Células Cultivadas , Cartilla de ADN/genética , Modelos Animales de Enfermedad , Femenino , Humanos , Inyecciones , Inyecciones Intraperitoneales , Riñón/virología , Pulmón/virología , Masculino , Sarampión/genética , Sarampión/inmunología , Virus del Sarampión/fisiología , Proteína Cofactora de Membrana , Ratones , Ratones Endogámicos BALB C , Ratones Transgénicos , ARN Viral/genética , ARN Viral/aislamiento & purificación , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Replicación ViralRESUMEN
Plasmids encoding the measles virus hemagglutinin (HA) and nucleoprotein (NP) proteins inoculated into the skin of BALB/c mice by the gene gun method induced both humoral and cytotoxic lymphocyte class I-restricted immune responses. Although intramuscular immunization induces the immunoglobulin G2a (IgG2a) antibody isotype for both antigens, with gene gun immunization, the NP still generated mainly IgG2a and the major isotype induced by the HA was IgG1. Interestingly, gene gun coimmunization of HA and NP plasmids resulted in a dominant IgG1 HA response and the switching of antibodies generated against the NP to the IgG1 isotype.
Asunto(s)
Antígenos Virales/inmunología , ADN Viral , Hemaglutininas Virales/inmunología , Inmunoglobulina G/inmunología , Vacuna Antisarampión/inmunología , Virus del Sarampión/inmunología , Nucleoproteínas/inmunología , Vacunación , Vacunas Sintéticas/inmunología , Proteínas Virales/inmunología , Animales , Femenino , Hemaglutininas Virales/genética , Isotipos de Inmunoglobulinas/inmunología , Ratones , Ratones Endogámicos BALB C , Ratones Endogámicos C3H , Ratones Endogámicos C57BL , Ratones Endogámicos DBA , Proteínas de la Nucleocápside , Nucleoproteínas/genética , Linfocitos T Citotóxicos/inmunología , Proteínas Virales/genéticaRESUMEN
CD36 is a cell surface receptor that has been shown to interact with a large variety of ligands including thrombospondin, collagen, Plasmodium falciparum-infected erythrocytes, apoptotic neutrophils, modified low density lipoproteins, anionic phospholipids and long chain fatty acids. A number of these CD36 ligands elicit the transduction of intracellular signals involved in cell activation and internalization of bound ligands. The engagement of CD36 possibly activates three cytosolic protein tyrosine kinases that are presumably associated with the C-terminal cytoplasmic tail of CD36. However, the mechanisms by which CD36 functions in ligand binding and signal transduction are poorly understood. In the present study, a membrane-bound and a truncated soluble form of CD36 were expressed in HeLa cells and analyzed by velocity-gradient centrifugation and chemical cross-linking. We show that membrane CD36 exists predominantly as a monomer but a homodimeric form is also found. In contrast, soluble CD36 sedimented in sucrose gradient as a monomer. However, when incubated with thrombospondin, the membrane form of CD36 predominantly sedimented as a dimer whereas soluble CD36 was monomeric. This study shows that thrombospondin has the ability to induce dimerization of CD36 and may be implicated in the signal transduction capacity of this adhesion molecule.
Asunto(s)
Antígenos CD36/metabolismo , Membrana Celular/metabolismo , Glicoproteínas de Membrana/farmacología , Antígenos CD36/química , Antígenos CD36/efectos de los fármacos , Dimerización , Células HeLa , Humanos , TrombospondinasRESUMEN
Despite the development of an efficient specific immune response during measles virus (MV) infection, an immunosuppression occurs contributing to secondary infections. To study the role of nucleocapsid protein (NP) in MV-induced immunosuppression, we produced recombinant MV NP. Purified recombinant NP exhibited biochemical, antigenic, and tridimensional structure similar to viral NP. By flow cytometry, we showed that viral or recombinant NP bound to human and murine B lymphocytes, but not to T lymphocytes. This binding was specific, independent of MHC class II expression, and dependent of the B lymphocyte activation state. The murine IIA1. 6 B cell line, deficient in the Fc receptor for IgG (FcgammaRII) expression, did not bind NP efficiently. Transfected IIA1.6 cells expressing either murine FcgammaRIIb1 or b2, or human FcgammaRIIa, b1*, or b2 isoforms efficiently bound NP. Furthermore, this binding was inhibited up to 90% by monoclonal antibodies 2.4G2 or KB61 specific for murine and human FcgammaRII, respectively. Finally, the in vitro Ig synthesis of CD40- or Ig-activated human B lymphocytes in the presence of interleukin (IL)-2 and IL-10 was reduced by 50% in the presence of recombinant NP. These data demonstrate that MV NP binds to human and murine FcgammaRII and inhibits in vitro antibody production, and therefore suggests a role for NP in MV-induced immunosuppression.
Asunto(s)
Formación de Anticuerpos , Linfocitos B/fisiología , Nucleoproteínas/fisiología , Receptores de IgG/fisiología , Proteínas Virales/fisiología , Animales , Células Cultivadas , Humanos , Tolerancia Inmunológica , Sarampión/inmunología , Ratones , Proteínas de la Nucleocápside , Receptores de Antígenos de Linfocitos B/fisiologíaRESUMEN
We have investigated the class I-restricted CTL response specific for measles virus haemagglutinin (HA) in the spleens of mice immunized by various mucosal routes with a DNA plasmid carrying the HA gene (pV1j-HA). A single immunization with recombinant DNA injected in the buccal mucosa induced an HA-specific CTL response. Similarly, nasal immunization with the DNA vaccine induced primary CTLs against measles virus HA. Booster immunization did not enhance the CTL activity. Oral or intrajejunal immunization with the plasmid induced a CTL response of lower magnitude. However, this could be potentiated by co-administration of the mucosal adjuvant cholera toxin or cationic lipids (DOTAP). These data show that a CTL response can be generated by mucosal vaccination using DNA vaccines.